RxDoctor Payments Data

Jacques Benun

Pediatrics · Austin, TXNPI 1952355471

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,543 of the $3,581 with a category attached, or 71.0%. 5 manufacturers reported payments, led by Astrazeneca UK Limited at 51.6% of the total. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,581in general payments, 2019–2025

Across 34 payments — averaging $105.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$2K
  • Eli Lilly$2K
  • Corcept Therapeutics$81
  • Novo Nordisk$24
  • Abbott$13
$1,336,687in research payments, 2019–2025

Across 248 payments — averaging $5389.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$457K
  • GSK$373K
  • Sanofi Pasteur Inc.$189K
  • Eli Lilly$184K
  • AstraZeneca$118K
  • Sanofi US Services Inc.$12K
  • plus $2K from 1 others

What the payments were for

  • Travel & lodging$2,54371%
  • Food & beverage$1,03829%

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited10$1,849
Eli Lilly21$1,614
Corcept Therapeutics1$81
Novo Nordisk1$24
Abbott1$13

How this compares

$3,581 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.

See all pediatrics providers in Texas

Other pediatrics in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →